Amanda L. Robichaud
Impact in
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- CRISPR and Genetic Engineering
- Histone Deacetylase Inhibitors Research
- RNA Research and Splicing
-
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 2
-
- Advanced Breast Cancer Therapies 2
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Kimberly Stegmaier (9 shared papers)Amy Saur Conway (5 shared papers)Joseph D. Mancias (2 shared papers)Miljan Kuljanin (2 shared papers)Nathanael S. Gray (2 shared papers)James E. Bradner (1 shared paper)Alan L. Leggett (1 shared paper)Behnam Nabet (1 shared paper)
- Journals
- Cancer Discovery (2 papers)Cancer Research (2 papers)The Journal of Experimental Medicine (1 paper)Clinical Cancer Research (1 paper)Blood Advances (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Amanda L. Robichaud
9 papers receiving 382 citations
Peers
Comparison fields: 5 of 44
- Molecular Biology 283
- Oncology 97
- Hematology 33
- Cancer Research 43
- Pulmonary and Respiratory Medicine 56
Countries citing papers authored by Amanda L. Robichaud
This map shows the geographic impact of Amanda L. Robichaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda L. Robichaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda L. Robichaud more than expected).
Fields of papers citing papers by Amanda L. Robichaud
This network shows the impact of papers produced by Amanda L. Robichaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda L. Robichaud. The network helps show where Amanda L. Robichaud may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda L. Robichaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 173 | |
| 2 | 2018 | 64 | |
| 3 | 2018 | 47 | |
| 4 | 2021 | 38 | |
| 5 | 2019 | 26 | |
| 6 | 2021 | 24 | |
| 7 | 2022 | 8 | |
| 8 | 2020 | 5 | |
| 9 | 2018 | 1 |
About Amanda L. Robichaud
Amanda L. Robichaud is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Neurology and Surgery, having authored 9 papers that have together received 386 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (2 papers), Advanced Breast Cancer Therapies (2 papers), Neuroblastoma Research and Treatments (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Acute Myeloid Leukemia Research (1 paper), Lung Cancer Research Studies (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Molecular Biology (283 citations), Oncology (97 citations), Hematology (33 citations), Cancer Research (43 citations) and Pulmonary and Respiratory Medicine (56 citations). Amanda L. Robichaud has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Kimberly Stegmaier, Amy Saur Conway, Joseph D. Mancias, Miljan Kuljanin, Nathanael S. Gray, James E. Bradner, Alan L. Leggett, Behnam Nabet, Bo Kyung A. Seong and Fleur M. Ferguson. Their work appears in journals such as Cancer Discovery, Cancer Research, The Journal of Experimental Medicine, Clinical Cancer Research and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.